Evropská unie - estonština - EMA (European Medicines Agency)

mylan ireland limited - rivaroksabaan - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombootilised ained - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Estonsko - estonština - Ravimiamet

grindeks as - atsetüülsalitsüülhape - tablett - 500mg 50tk; 500mg 20tk

Estonsko - estonština - Ravimiamet

krka, d.d., novo mesto - atsetüülsalitsüülhape - gastroresistentne tablett - 160mg 90tk; 160mg 84tk; 160mg 100tk; 160mg 30tk; 160mg 28tk; 160mg 60tk; 160mg 50tk

Estonsko - estonština - Ravimiamet

bayer uab - atsetüülsalitsüülhape - tablett - 500mg 20tk; 500mg 100tk; 500mg 50tk

Estonsko - estonština - Ravimiamet

bayer uab - atsetüülsalitsüülhape - gastroresistentne tablett - 100mg 98tk

Estonsko - estonština - Ravimiamet

pharmaswiss ceska republika s.r.o. - atsetüülsalitsüülhape - gastroresistentne tablett - 75mg 50tk; 75mg 30tk; 75mg 10tk; 75mg 500tk; 75mg 100tk; 75mg 28tk; 75mg 56tk; 75mg 60tk

Estonsko - estonština - Ravimiamet

krka, d.d., novo mesto - atsetüülsalitsüülhape - gastroresistentne tablett - 75mg 60tk; 75mg 56tk; 75mg 30tk; 75mg 100tk; 75mg 50tk; 75mg 90tk

Estonsko - estonština - Ravimiamet

krka, d.d., novo mesto - atsetüülsalitsüülhape - gastroresistentne tablett - 100mg 30tk; 100mg 60tk; 100mg 56tk; 100mg 50tk; 100mg 100tk; 100mg 90tk; 100mg 168tk; 100mg 28tk

Estonsko - estonština - Ravimiamet

g.l. pharma gmbh - atsetüülsalitsüülhape - gastroresistentne tablett - 100mg 100tk; 100mg 30tk

Estonsko - estonština - Ravimiamet

bayer uab - atsetüülsalitsüülhape - kihisev tablett - 324mg 10tk